Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Rutherrin

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Apr 17, 2022 5:37am

178 Views

Post# 34608153

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

No intention to impugn fellow posters OM many if not most of whom have far greater knowledge/expertise in this area than I do - and that includes you!

Continue to doubt though whether unquestioning patience is any sort of virtue in the world of small biotech where value can (and quite suddenly) be diminished or even destroyed by the progress of others?

This from today’s press:

https://www.dailymail.co.uk/health/article-10724471/Experts-hail-new-double-drug-therapy-boost-survival-lung-cancer-patients.html

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism